Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potential
PLOS Pathogens · 23.04.2026 · 22 (4) · e1013739
DOI: 10.1371/journal.ppat.1013739 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 23.04.2026. Verfasst von Bette Korber und 15 weiteren Autor:innen. Beteiligte Einrichtung: New Mexico Consortium, Los Alamos, New Mexico, United States of America. Hauptthemen laut MEDLINE: HIV-1, HIV Antibodies, env Gene Products, Human Immunodeficiency Virus, HIV Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Gates Foundation, NIH.
Abstract (Originalsprache)
Although a protective HIV-1 vaccine has not yet been realized, significant progress has been made in vaccine designs that trigger B cell lineages with potential to produce broadly neutralizing antibodies (bnAbs). Advancing these strategies by optimizing vaccine boosting regimens requires early detection of maturing antibodies with neutralizing activity against native envelope glycoprotein (Env) trimers and streamlined strategies to identify antibodies as they begin to manifest desired levels of breadth and potency. Thus, we designed three types of pseudovirus screening panels based on Envs of contemporary HIV-1 isolates to facilitate detection of bnAb lineages that are on favorable trajectories during a vaccination course. The panels were selected from Tier 2 Transmitted Founder Lineage (TFL) HIV-1 Envs from placebo participants in the Antibody Mediated Prevention (AMP) efficacy trials. Using 15 bnAbs to evaluate the neutralization sensitivity of the viruses, we selected 8-member bnAb class-specific panels most sensitive to bnAbs representing their class: V2-apex, V3-glycan, CD4-receptor binding site (CD4bs), Membrane-Proximal External Region (MPER), or fusion peptide (FP). Next, we combined the most sensitive viruses among the class-specific panels to create a 12-virus panel to enable optimal detection of low-titer bnAb activity across epitope specificities. Finally, as HIV-1 continues to evolve greater levels of antigenic diversity and as current global pseudoviruses bnAb panels rely on viruses collected more than twenty years ago, we showed the importance of using contemporary viral panels to assess bnAb breadth and potency and designed a 12-virus panel representative of the spectrum neutralization profiles among AMP placebo viruses. We characterized pseudoviruses bearing each selected Env using standardized human sera to confirm their Tier 2 status and biological relevance. These updated panels enable sensitive screening of neutralization activity in vaccine studies and can also provide a realistic assessment of the expected breadth and potency of maturing responses against contemporary HIV-1 Envs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- New Mexico Consortium, Los Alamos, New Mexico, United States of America.
- Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
- SAMRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
- National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
- Department of Surgery, Duke University, Durham, North Carolina, United States of America.
- Duke Human Vaccine Institute and Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.
ORCID-Profile: Elena E Giorgi
Förderung
- NIAID NIH HHS
- Gates Foundation
- NIH
Zitieren
APA
Korber, B., Seaman, M. S., Mkhize, N. N., Greene, K., Gao, H., Shen, X., Domin, E., Tang, H., Theiler, J., Wagh, K., Moore, P. L., Williamson, C., Mullins, J. I., Doria-Rose, N. A., Montefiori, D., & Giorgi, E. E. (2026). Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potential. PLOS Pathogens, 22(4), e1013739. https://doi.org/10.1371/journal.ppat.1013739
Vancouver
Korber B, Seaman MS, Mkhize NN, Greene K, Gao H, Shen X, et al. Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potential. PLOS Pathogens. 2026;22(4):e1013739. doi:10.1371/journal.ppat.1013739
BibTeX
@article{Korber2026,
author = {Korber, Bette and Seaman, Michael S and Mkhize, Nonhlanhla N and Greene, Kelli and Gao, Hongmei and Shen, Xiaoying and Domin, Elizabeth and Tang, Haili and Theiler, James and Wagh, Kshitij and Moore, Penny L and Williamson, Carolyn and Mullins, James I and Doria-Rose, Nicole A and Montefiori, David and Giorgi, Elena E},
title = {Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potential},
journal = {PLOS Pathogens},
year = {2026},
volume = {22},
number = {4},
pages = {e1013739},
doi = {10.1371/journal.ppat.1013739}
}
EUVIMED